We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 74.00 | 73.80 | 75.60 | 0.00 | 01:00:00 |
Hot Features
Premium
RNS Number:7533Q
CeNeS Pharmaceuticals PLC
09 October 2003
CENES PHARMACEUTICALS PLC ("the Company")
HOLDING IN COMPANY
The Company was informed on 9th October 2003 that, as a result of a purchase of
1,000,000 ordinary shares of 1p each in the capital of the Company ("Ordinary
Shares") on 8th October 2003, ISIS Asset Management Plc has an interest in
21,200,000 Ordinary Shares, representing 10.02 per cent. of the issued share
capital of the Company. This interest includes the material interests of Active
Capital Trust, a client of ISIS, and the Ordinary Shares are registered in the
name of Chase Nominees Limited.
Further information
Neil Clark, CeNeS Pharmaceuticals plc 01223 266 466
This information is provided by RNS
The company news service from the London Stock Exchange
EN
HOLUKUBROWRRRAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
